Formation

Diagnostic Biochips emerged from engineering services company Scientific & Biomedical Microsystems (SBM) in 2013 to commercialize technology developed under contract with the Howard Hughes Medical Institute’s Janelia Research Campus. With over $6M of R&D funding from the NIH and DARPA, Diagnostic Biochips has been expanding our preclinical neurosensor’s capabilities.

Building Momentum

A lack of appropriately scaled and widely applicable tools to study structures at the neural network level was identified as one of the barriers to allowing scientists to develop a detailed, functional description of the brain. In 2014, a consortium of federal agencies including the NIH, NSF, DARPA, the FDA, reached the same conclusion. As a result, The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, a multi-decadal, multi-billion dollar program, was launched to accelerate the understanding of the brain, and advance therapies and cures for the growing burden of brain disease. We are proud to be aligned.

Current Focus

By accelerating the development and application of innovative technologies, researchers will be able to produce a revolutionary new picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. Long desired by researchers seeking new ways to treat, cure and even prevent brain disorders, this picture will fill major gaps in our current knowledge and provide unprecedented opportunities for exploring exactly how the brain enables the human body to record, process, utilize, store and retrieve vast quantities of information, all at the speed of thought.

Diagnostic Biochips products

Micro EcOG

Micro EcOG

Micro EcOG